CanDiag Secures $500,000 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    9201 University City Boulevard Charlotte, NC 28223 USA
  • Company Description
    CanDiag, Inc. is a University of North Carolina Charlotte (UNCC) spin-off that was incorporated in November 2010. We have a worldwide exclusive license to a patented tumor antibody that has been used to develop a blood test for the early detection of breast cancer.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

Trending on Xconomy